Source comparison
CJC-1295 No DAC Fat Loss Complete Guide 2026: Comparison Table
Before selecting a growth hormone secretagogue protocol, understanding the mechanistic and practical differences between CJC-1295 variants and alternative peptides is essential. CJC-1295 No DAC ~30 min 1–3x daily Pulsatile (peaks in 30–60 min, clears in 2–3 hr
This comparison does not assign a generated winner or score.
- Before selecting a growth hormone secretagogue protocol, understanding the mechanistic and practical differences between CJC-1295 variants and alternative peptides is essential.
- CJC-1295 No DAC
- ~30 min
- 1–3x daily
- Pulsatile (peaks in 30–60 min, clears in 2–3 hrs)
- GHRH receptor agonist
- Nocturnal GH amplification, pre-workout lipolysis
- Lyophilized: -20°C; Reconstituted: 2–8°C, use within 28 days
- Best for mimicking physiological GH pulses; requires consistent daily dosing; pairs well with GHRPs
- CJC-1295 With DAC
- 6–8 days
- 1x weekly
- Sustained elevation (steady-state receptor occupancy)
- GHRH receptor agonist with albumin binding
- Long-term GH elevation without daily injections
- Convenient dosing but risks receptor desensitization; less aligned with natural pulsatile secretion
- Ipamorelin
- ~2 hours
- Pulsatile (peaks in 20–40 min)
- Ghrelin receptor agonist (GHRP)
- Synergistic pairing with GHRH analogs
- Minimal cortisol/prolactin elevation; cleanest GHRP profile; ideal stacking partner for CJC no DAC
- GHRP-2
- Pulsatile (peaks in 20–30 min)
- GH pulse amplification; appetite stimulation
- Stronger GH pulse than ipamorelin but may increase cortisol/prolactin; not ideal for fat loss-focused protocols
- Tesamorelin
- 1x daily
- Pulsatile (peaks in 30–60 min)
- GHRH receptor agonist (FDA-approved for lipodystrophy)
- Visceral fat reduction in HIV-associated lipodystrophy
- Only FDA-approved GHRH analog; proven visceral fat reduction; requires prescription; higher cost
- MK-677 (Ibutamoren)
- 24 hours
- 1x daily (oral)
- Sustained elevation (continuous receptor activation)
- Ghrelin receptor agonist (oral mimetic)
- Lean mass preservation, appetite increase
- Room temperature (stable as oral compound)
- Oral convenience but sustained ghrelin activation increases appetite significantly; not ideal for fat loss